Skip Header

1 - 25 of 60 results for author:"Wu T.C." in Literature citations

Page of 3 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (280)

Nanog signaling in cancer promotes stem-like phenotype and immune evasion.

Noh K.H., Kim B.W., Song K.H., Cho H., Lee Y.H., Kim J.H., Chung J.Y., Kim J.H., Hewitt S.M., Seong S.Y. et al.

J. Clin. Invest. 122:4077-4093(2012) · Mapped (2)

Inhibition of lysosome degradation on autophagosome formation and responses to GMI, an immunomodulatory protein from Ganoderma microsporum.

Hsin I.L., Sheu G.T., Jan M.S., Sun H.L., Wu T.C., Chiu L.Y., Lue K.H., Ko J.L.

Br. J. Pharmacol. 167:1287-1300(2012) · Mapped (9)

MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1.

Zhang H.S., Wu T.C., Sang W.W., Ruan Z.

Biochim. Biophys. Acta 1823:1017-1023(2012) · Mapped (7)

Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.

Noh K.H., Lee Y.H., Jeon J.H., Kang T.H., Mao C.P., Wu T.C., Kim T.W.

Cancer Res. 72:1717-1727(2012) · Mapped (2)

Significant elevation of plasma cathepsin B and cystatin C in patients with community-acquired pneumonia.

Lee Y.T., Chen S.C., Shyu L.Y., Lee M.C., Wu T.C., Tsao S.M., Yang S.F.

Clin. Chim. Acta 413:630-635(2012) · Mapped (10)

The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China.

Ye J.R., Lu H.Y., Wang W.S., Guo L., Xin R.L., Yu S.Q., Wu T.C., Zeng Y., He X.

AIDS Res. Hum. Retroviruses 28:418-423(2012) · UniProtKB (272)

Plasma ferritin levels, genetic variations in HFE gene, and coronary heart disease in Chinese: a case-control study.

Shi Y., Zhou L., Huang L.H., Lian Y.T., Zhang X.M., Guo H., Wu T.C., Cheng L.X., He M.A.

Atherosclerosis 218:386-390(2011) · Mapped (5)

Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract.

Chen J.S., Huang P.H., Wang C.H., Lin F.Y., Tsai H.Y., Wu T.C., Lin S.J., Chen J.W.

Atherosclerosis 214:301-309(2011) · Mapped (17)

Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-kappaB activation.

Wu H.H., Cheng Y.W., Chang J.T., Wu T.C., Liu W.S., Chen C.Y., Lee H.

Oncogene 29:4330-4340(2010) · Mapped (7)

Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity.

Kang T.H., Noh K.H., Kim J.H., Bae H.C., Lin K.Y., Monie A., Pai S.I., Hung C.F., Wu T.C., Kim T.W.

Cancer Res. 70:3062-3070(2010) · Mapped (4)

Mechanical stretching induces osteoprotegerin in differentiating C2C12 precursor cells through noncanonical Wnt pathways.

Yu H.C., Wu T.C., Chen M.R., Liu S.W., Chen J.H., Lin K.M.

J. Bone Miner. Res. 25:1128-1137(2010) · Mapped (3)

The role of RANTES as a crucial downstream cytokine in calcineurin-dependent VSMC apoptosis stimulated by INFgamma and CD40L.

Peng Y.D., Cheng L.X., Zeng Q.T., Shi Y., Bao X.X., Mao X.B., Ji Q.W., Li S.N., Guo M., Liang Z.S. et al.

Cell Biol. Int. 34:447-453(2010) · Mapped (3)

Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.

Huang S.S., Wu T.C., Lin S.J., Chen J.W.

Circ. J. 73:2282-2287(2009) · Mapped (3)

Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion.

Wu J.F., Wu T.C., Chen C.H., Ni Y.H., Chen H.L., Hsu H.Y., Chang M.H.

Gastroenterology 138:165-72.e1-3(2010) · Mapped (7)

Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells.

Huang P.H., Chen Y.H., Wang C.H., Chen J.S., Tsai H.Y., Lin F.Y., Lo W.Y., Wu T.C., Sata M., Chen J.W. et al.

Arterioscler. Thromb. Vasc. Biol. 29:1179-1184(2009) · Mapped (5)

Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.

Chiang K.H., Huang P.H., Huang S.S., Wu T.C., Chen J.W., Lin S.J.

Coron. Artery Dis. 20:267-273(2009) · Mapped (36)

Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.

Chien W.P., Wong R.H., Wu T.C., Cheng Y.W., Chen C.Y., Lee H.

Ann. Surg. Oncol. 16:1918-1924(2009) · Mapped (32)

Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis.

Rowley J., Monie A., Hung C.F., Wu T.C.

Eur. J. Immunol. 39:491-506(2009) · Mapped (11)

Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.

Rowley J., Monie A., Hung C.F., Wu T.C.

J. Immunol. 181:8237-8247(2008) · Mapped (15)

Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.

Wu J.Y., Wang J., Lai J.C., Cheng Y.W., Yeh K.T., Wu T.C., Chen C.Y., Lee H.

Ann. Surg. Oncol. 15:3272-3277(2008) · Mapped (3)

Diagnosis of BSEP/ABCB11 mutations in Asian patients with cholestasis using denaturing high performance liquid chromatography.

Chen H.L., Liu Y.J., Su Y.N., Wang N.Y., Wu S.H., Ni Y.H., Hsu H.Y., Wu T.C., Chang M.H.

J. Pediatr. 153:825-832(2008) · Mapped (5)

Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer.

Cheng Y.W., Lee H., Shiau M.Y., Wu T.C., Huang T.T., Chang Y.H.

Clin. Cancer Res. 14:4705-4712(2008) · Mapped (11)

Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.

Lai J.C., Cheng Y.W., Goan Y.G., Chang J.T., Wu T.C., Chen C.Y., Lee H.

DNA Repair (Amst.) 7:1352-1363(2008) · Mapped (35)

Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.

Huang P.H., Lu T.M., Wu T.C., Lin F.Y., Chen Y.H., Chen J.W., Lin S.J.

Coron. Artery Dis. 19:187-193(2008) · Mapped (4)

Study on the association of -689C/T polymorphism in the PPARgamma2 promoter with myocardial infarction.

Li J.P., Cheng L.X., He M.A., Wu T.C.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25:19-22(2008) · Mapped (9)

to top of page·

Page of 3 | Next »